432 followers
In the absence of other modern therapies, VTD, VTDC and TAD have a role for induction in Ndx SCT-eligible #myeloma https://t.co/NhH8G2Nrws
In the absence of other modern therapies, VTD, VTDC and TAD have a role for induction in Ndx SCT-eligible #myeloma https://t.co/NhH8G2Nrws
Meta-analysis finds VTD, VTDC, & TAD regimens most beneficial byORR, OS, and PFS for transplant-eligible #myeloma: https://t.co/HzoG8Y3P3y. https://t.co/zTuRDyBFsY